Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cholesterol: blood level and control by Swiss physicians]

C Nigg1, F Gutzwiller

  • 1Institut für Sozial- und Präventivmedizin, Zürich.

Schweizerische Medizinische Wochenschrift
|February 25, 1995
PubMed
Summary

High cholesterol (hypercholesterolemia) contributes to coronary heart disease. The Swiss Heart Foundation

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Archives of gynecology and obstetrics·2016
Same author

Chemotherapy of experimental melioidosis in mice.

Antibiotics & chemotherapy (Northfield, Ill.)·2014
Same author

Missed epidemics and missing links: international birth cohort trends in multiple sclerosis.

European journal of neurology·2012
Same author

Developing a measure to evaluate a positive youth development program for Native Hawaiians: the Hui Mālama o ke Kai rubrics of Hawaiian values.

Asia-Pacific journal of public health·2011
Same author

The enhancement and properties of the complement-fixing antigens of lymphogranuloma venereum.

Federation proceedings·2010
Same author

Studies on lymphogranuloma venereum complement-fixing antigens the solubility in ether of an active fraction.

Journal of immunology (Baltimore, Md. : 1950)·2010

Area of Science:

  • Cardiovascular disease research
  • Public health initiatives
  • Medical education

Background:

  • Coronary heart disease (CHD) poses significant morbidity, mortality, and economic burdens in Switzerland.
  • Hypercholesterolemia is a primary driver of atherosclerosis and a key risk factor for CHD.
  • Physician awareness of hypercholesterolemia's significance and patient understanding are suboptimal, leading to confusion.

Framework:

  • The Cholesterin Informations Program aims to establish an objective, science-based information strategy.
  • The program targets both healthcare professionals and the general public.

Implementation:

  • Developing and disseminating evidence-based information on cholesterol management.
  • Addressing public and professional misconceptions surrounding hypercholesterolemia.

Implications:

  • Enhancing the management of cardiovascular risk factors in Switzerland.
  • Improving public health outcomes by promoting better understanding and management of hypercholesterolemia.
  • Contributing to the reduction of CHD morbidity and mortality through targeted health communication.

Related Experiment Videos